Researchers conducted a case-control study to examine the associations between polygenic risk scores for schizophrenia and other mental disorders with the development of cannabis use disorder.
Cannabis use among patients with multiple sclerosis (MS) is more likely where cannabis laws are more permissive.
The Science of Cannabis Symposium welcomed both clinicians and legal experts and aimed to provide medical and legal education for healthcare providers who are considering the use of cannabis in their medical practice.
Individuals with chronic pain who use daily cannabis have lower odds of using illicit opioids.
Patients with treatment resistant depression (TRD), defined as at least 3 treatment trials within a single depressive episode, were matched with 5 controls with non-treatment–resistant depression.
Contrary to expectations, the prevalence of cannabis use disorder (CUD) decreased significantly among individuals reporting daily/almost daily cannabis use between 2002 and 2016.
Cannabis use disorder (CUD) has increased among adolescents and adults (≥26 years) after recreational marijuana legalization (RML) enactment.
The researchers found that the incidence of CUD was 2.6% in arrhythmia inpatients.
At Psych Congress 2018, Andrew Penn from the UCSF School of Nursing provides insight into the use of CBD in clinical practice.
Participants with current moderate to severe chronic pain and opioid use were assessed for substance abuse problems.
